Skip to main content

US puts further squeeze on WuXi AppTec

The US House of Representatives Committee on Oversight & Accountability committee has approved the Biosecure Act, which will require American companies to cease working with WuXi AppTec, among other Chinese biotechs, by 2032. This follows a vote on an earlier draft by the Senate’s Homeland Security & Governmental Affairs committee. The Act must now go through votes in both chambers and be signed into law by the President.

Subscribe to WuXi Biologics